Life Science Combo Device Innovations
Drug-device combinations are becoming the latest tools to target complex disease diagnosis while focusing on effective outcomes. Here’s a look at some of our innovations we’re bringing to life.
Our work is focused on discovering cures for specific cancers and debilitating rare diseases and cancers by focusing on cellular regeneration. This has led us toward developing a range of combination devices that specifically targets malignancies for patients who are diagnosed with rare diseases and cancers.
Not replacement. Regeneration.
Project Hercules sets the stage as one of the first
combination products that are geared toward an orthogenic platform. A cross-pollination of osteoinductive, osseointegrative and osteogenic elements; we’re geared toward targeting clinical indications toward osteopenia, arthrodesis and osteonecrosis.
Unlocking the secrets of the brain.
Project Icarus sets the stage on how to attack malformations of the brain that leads up to cancerous development of tumors that are diagnosed DIPG grade IV. 100% Fatal to adolescents and those younger than that group even with inclusion of radiation therapy and chemotherapy, Icarus is a novel regenerative absorb-able matrix (derivative of Hercules) that focuses on mitigating abnormal glial tissue evolution.
Fighting disease from the root. Of teeth.
From Gardiner’s Syndrome to orthodontic necrosis, from the near 7000 diseases that exists today, 12% are found in the mouth. This innovation is a regenerative mouth brace that focuses on bone and calcium growth that enables restorative surgery without the drill.